Skip to Content

EHA24: LBA – Potential Frontline Treatment for Elderly Patients with Untreated Mantle Cell Lymphoma

Just released at this year’s EHA congress, this late-breaking abstract shows the promising efficacy and safety of acalabrutinib combined with bendamustine and rituximab for elderly patients with untreated mantle cell lymphoma.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top